Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
FLERIE Stock Chart & Stats
kr37.25
-kr0.13(-0.28%)
At close: 4:00 PM EST
kr37.25
-kr0.13(-0.28%)
Day’s Range― - ―
52-Week Rangekr36.00 - kr50.45
Previous CloseN/A
Volume1.84K
Average Volume (3M)10.31K
Market Cap
kr2.83B
Enterprise Valuekr2.37B
Total Cash (Recent Filing)kr540.20M
Total Debt (Recent Filing)kr3.70M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Apr 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding77,455,960
10 Day Avg. Volume8,358
30 Day Avg. Volume10,307
Financial Highlights & Ratios
PEG Ratio1.22
Price to Book (P/B)0.74
Price to Sales (P/S)411.07
P/FCF Ratio-164.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLERIE FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was kr36.00 and its highest was kr50.45 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is kr2.83B.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is Apr 15, 2026 which is in 82 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
Currently, no data Available
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Overvalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 77,455,960 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in SE:FLERIE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
InDex Pharmaceuticals Holding AB
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Technical Analysis
SynAct Pharma AB
―
C-Rad AB Class B
―
Vicore Pharma Holding AB
―
Guard Therapeutics International AB
―
Xspray Pharma AB
―